AI Predictions Dashboard
Multi-Agent Predictive Intelligence powered by SEC 8-K filings analysis. Real-time insights for pharmaceutical and biotech stocks.
Event Distribution
Perrigo Company plc
Perrigo Company plc (PRGO) released financial results. Analysis indicates limited probability of success (1%) based on clinical profile and regulatory outlook.
BeiGene, Ltd.
BeiGene, Ltd. (BGNE) released financial results. Analysis indicates limited probability of success (5%) based on clinical profile and regulatory outlook.
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. (IONS) released financial results. Analysis indicates limited probability of success (5%) based on clinical profile and regulatory outlook.
Elanco Animal Health Inc.
Elanco Animal Health Inc. (ELAN) released financial results. Analysis indicates limited probability of success (5%) based on clinical profile and regulatory outlook.
BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. (BMRN) released financial results. Analysis indicates limited probability of success (5%) based on clinical profile and regulatory outlook.
Gilead Sciences, Inc.
Gilead Sciences, Inc. (GILD) released strategic transaction. Analysis indicates limited probability of success (5%) based on clinical profile and regulatory outlook.
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. (HALO) released financial results. Analysis indicates limited probability of success (5%) based on clinical profile and regulatory outlook.
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated (VRTX) released financial results. Analysis indicates limited probability of success (5%) based on clinical profile and regulatory outlook.
Moderna, Inc.
Moderna, Inc. (MRNA) released clinical trial results. Analysis indicates limited probability of success (5%) based on clinical profile and regulatory outlook.
Moderna, Inc.
Moderna, Inc. (MRNA) released financial results. Analysis indicates limited probability of success (5%) based on clinical profile and regulatory outlook.
BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. (BMRN) released strategic transaction. Analysis indicates limited probability of success (5%) based on clinical profile and regulatory outlook.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. (ALNY) released financial results. Analysis indicates limited probability of success (5%) based on clinical profile and regulatory outlook.
Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd (TEVA) released financial results. Analysis indicates limited probability of success (5%) based on clinical profile and regulatory outlook.
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. (HALO) released financial results. Analysis indicates limited probability of success (5%) based on clinical profile and regulatory outlook.
Amgen Inc.
Amgen Inc. (AMGN) released financial results. Analysis indicates limited probability of success (5%) based on clinical profile and regulatory outlook.
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc (JAZZ) released pipeline update. Analysis indicates limited probability of success (1%) based on clinical profile and regulatory outlook.
Eli Lilly and Company
Eli Lilly and Company (LLY) released financial results. Analysis indicates limited probability of success (1%) based on clinical profile and regulatory outlook.
BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. (BMRN) released clinical trial results. Analysis indicates limited probability of success (5%) based on clinical profile and regulatory outlook.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. (REGN) released financial results. Analysis indicates high probability of success (75%) based on clinical profile and regulatory outlook.
Merck & Co., Inc.
Merck & Co., Inc. (MRK) released financial results. Analysis indicates moderate probability of success (55%) based on clinical profile and regulatory outlook.
Pfizer Inc.
Pfizer Inc. (PFE) released financial results. Analysis indicates limited probability of success (10%) based on clinical profile and regulatory outlook.
AbbVie Inc.
AbbVie Inc. (ABBV) released financial results. Analysis indicates moderate probability of success (65%) based on clinical profile and regulatory outlook.
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (BMY) released financial results. Analysis indicates moderate probability of success (65%) based on clinical profile and regulatory outlook.
Johnson & Johnson
Johnson & Johnson (JNJ) released financial results with an overall response rate of 45%. Analysis indicates high probability of success (70%) based on clinical profile and regulatory outlook.
BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. (BMRN) released financial results. Analysis indicates limited probability of success (5%) based on clinical profile and regulatory outlook.
Disclaimer: These AI-generated predictions are for informational purposes only and should not be considered financial advice. Always conduct your own research and consult with a licensed financial advisor before making investment decisions.